Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Bausch Health halts plan to IPO skin-care division, citing ‘challenging market conditions'
06:08pm, Thursday, 16'th Jun 2022
Bausch Health Cos. Inc. late Thursday said it has halted plans to proceed with the initial public offering of its skin-care business Solta Medical, citing market turmoil.
2 Cheap Stocks Trading at “Deal of the Century” Prices
04:13pm, Friday, 10'th Jun 2022
Simple value metrics are provenly bad at generating consistent returns, but that doesn't mean there aren't opportunities to be found. The post 2 Cheap Stocks Trading at “Deal of the Century” Price
Bausch Health Companies: 2022's Most Compelling Special Situation
10:13am, Friday, 10'th Jun 2022
BHC's stake in BLCO that is set to be distributed to shareholders is worth more than the current market capitalization of the entirety of BHC, giving investors a compelling return. The BLCO spinoff an
Why Is Bausch (BHC) Down 11.2% Since Last Earnings Report?
03:30pm, Thursday, 09'th Jun 2022 Zacks Investment Research
Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bausch + Lomb tops profit expectations but revenue comes up shy
07:17am, Wednesday, 08'th Jun 2022
Bausch + Lomb Corp. BLCO, -3.16% reported Wednesday first-quarter profit that topped expectations but revenue that came up short, as growth in vision care and surgical segment revenue was partially of
Implied Volatility Surging for Bausch (BHC) Stock Options
12:48pm, Monday, 06'th Jun 2022 Zacks Investment Research
Investors need to pay close attention to Bausch (BHC) stock based on the movements in the options market lately.
Top 5 Trades of Larry Robbins' Firm in the 1st Quarter
06:10pm, Thursday, 02'nd Jun 2022
Glenview Capital Management, the firm founded by Larry Robbins (Trades, Portfolio), disclosed in a regulatory filing that its top five trades during the first quarter included boosts to its holdings o
Bausch Health Companies Inc. (BHC) Management on Barclays High Yield Bond & Syndicated Loan Conference (Transcript)
04:23pm, Tuesday, 24'th May 2022
Bausch Health Companies Inc. (NYSE:BHC ) Barclays High Yield Bond & Syndicated Loan Conference May 24, 2022 12:00 PM ET Company Participants Tom Vadaketh - Chief Financial Officer Will Woodfield - Tre
New Strong Sell Stocks for May 19th
10:59am, Thursday, 19'th May 2022 Zacks Investment Research
ASX, CNMD, and BHC have been added to the Zacks Rank #5 (Strong Sell) List on May 19, 2022.
New Strong Sell Stocks for May 19th
08:17am, Thursday, 19'th May 2022
ASX, CNMD, and BHC have been added to the Zacks Rank #5 (Strong Sell) List on May 19, 2022.
Carvana, Coinbase junk bonds tumble Wednesday as layoffs, losses hit prices
11:04pm, Wednesday, 11'th May 2022 MarketWatch
High-yield, or "junk," bonds issued by Carvana and Coinbase were two of the three most-actively traded names on Wednesday.
Why Bausch Health Is Down More Than 24% Today
05:06pm, Tuesday, 10'th May 2022 The Motley Fool
The company shocked investors with its loss, although today may also be a major capitulation for the stock.
Bausch Health Companies: Headwinds, Again
04:20pm, Tuesday, 10'th May 2022
Bausch Health has seen a very tough 2022 as investors price in higher interest rates on its massive debt load and softer IPO of its subsidiary Bausch + Lomb. These are not encouraging trends, but the
Bausch (BHC) Q1 Earnings and Revenues Miss, Stock Down
03:37pm, Tuesday, 10'th May 2022 Zacks Investment Research
Bausch (BHC) misses on earnings and sales in the first quarter due to incremental macro pressures and a challenging supply chain environment.
Bausch Health Stock Sinks as Revenue Guidance Misses Forecasts
02:01pm, Tuesday, 10'th May 2022
The personal-care products company expects 2022 revenue of between $8.2 billion and $8.4 billion, below analysts' estimates.
